COMPOSITIONS OF ADAGRASIB AND mTOR INHIBITORS AND METHODS OF TREATMENT THEREWITH
US-2026097038-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Engstrom Lars Daniel patents
Engstrom Lars Daniel is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Engstrom Lars Daniel |
| Total patents | 26 |
| First publication | Feb 10, 2022 |
| Latest publication | Apr 9, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions of adagrasib and mTOR inhibitors and methods of treatment therewith
US-12527795-B2 · Jan 20, 2026 · US
Combination of palbociclib and adagrasib for lung cancer
US-12485122-B2 · Dec 2, 2025 · US
Combination therapies using prmt5 inhibitors and immune checkpoint inhibitors for the treatment of cancer
US-2025312344-A1 · Oct 9, 2025 · US
Combination therapies using prmt5 inhibitors and kras g12d inhibitors for the treatment of cancer
US-2025312343-A1 · Oct 9, 2025 · US
Combination therapies using prmt5 inhibitors and sos1 inhibitors for the treatment of cancer
US-2025312351-A1 · Oct 9, 2025 · US
Combination therapies
US-2025262213-A1 · Aug 21, 2025 · US
Combination therapies
US-12377101-B2 · Aug 5, 2025 · US
Combination therapies
US-2025213579-A1 · Jul 3, 2025 · US
Combination therapies
US-12336995-B2 · Jun 24, 2025 · US
Recent patents
Latest publications not already listed above.
Combination therapies
US-2025177399-A1 · Jun 5, 2025 · US
Combination therapies
US-2025108055-A1 · Apr 3, 2025 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2025073241-A1 · Mar 6, 2025 · US
Combination therapies
US-12208099-B2 · Jan 28, 2025 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2024423987-A1 · Dec 26, 2024 · US
Combination therapies using PRMT5 inhibitors for the treatment of cancer
US-12171765-B2 · Dec 24, 2024 · US
Combination therapies using prmt5 inhibitors for the treatment of cancer
US-2024398795-A1 · Dec 5, 2024 · US
Combination therapies using PRMT5 inhibitors for the treatment of cancer
US-12128048-B2 · Oct 29, 2024 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2022331324-A1 · Oct 20, 2022 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2022331323-A1 · Oct 20, 2022 · US
Combination therapies
US-2022096482-A1 · Mar 31, 2022 · US
Combination therapies
US-2022079947-A1 · Mar 17, 2022 · US
Combination therapies
US-2022054491-A1 · Feb 24, 2022 · US
Combination therapies
US-2022054492-A1 · Feb 24, 2022 · US
Combination therapies
US-2022040181-A1 · Feb 10, 2022 · US
Combination therapies
US-2022040182-A1 · Feb 10, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Mirati Therapeutics Inc | 26 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 26 |
| A61K45/06 | 26 |
| A61K31/519 | 23 |
| A61K31/5377 | 14 |
| A61K31/506 | 14 |